Literature DB >> 31948437

Dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca2+/calpain might contribute to postoperative cognitive dysfunction in aging mice.

Li-Li Qiu1, Wei Pan2, Dan Luo1, Guang-Fen Zhang1, Zhi-Qiang Zhou3, Xiao-Yun Sun3, Jian-Jun Yang4, Mu-Huo Ji5.   

Abstract

BACKGROUND: Postoperative cognitive decline (POCD) is a recognized clinical phenomenon characterized by cognitive impairments in patients following anesthesia and surgery, yet its underlying mechanism remains unclear. Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal plasticity, learning, and memory via activation of TrkB-full length (TrkB-FL) receptors. It has been reported that an abnormal truncation of TrkB mediated by calpain results in dysregulation of BDNF/TrkB signaling and is associated with cognitive impairments in several neurodegenerative disorders. Calpains are Ca2+-dependent proteases, and overactivation of calpain is linked to neuronal death. Since one source of intracellular Ca2+ is N-methyl-d-aspartate receptors (NMDARs) related and the function of NMDARs can be regulated by neuroinflammation, we therefore hypothesized that dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca2+/calpain might be involved in the pathogenesis of POCD.
METHODS: In the present study, 16-month-old C57BL/6 mice were subjected to exploratory laparotomy with isoflurane anesthesia to establish the POCD animal model. For the interventional study, mice were treated with either NMDAR antagonist memantine or calpain inhibitor MDL-28170. Behavioral tests were performed by open field, Y maze, and fear conditioning tests from 5 to 8 days post-surgery. The levels of Iba-1, GFAP, interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), NMDARs, calpain, BDNF, TrkB, bax, bcl-2, caspase-3, and dendritic spine density were determined in the hippocampus.
RESULTS: Anesthesia and surgery-induced neuroinflammation overactivated NMDARs and then triggered overactivation of calpain, which subsequently led to the truncation of TrkB-FL, BDNF/TrkB signaling dysregulation, dendritic spine loss, and cell apoptosis, contributing to cognitive impairments in aging mice. These abnormities were prevented by memantine or MDL-28170 treatment.
CONCLUSION: Collectively, our study supports the notion that NMDAR/Ca2+/calpain is mechanistically involved in anesthesia and surgery-induced BDNF/TrkB signaling disruption and cognitive impairments in aging mice, which provides one possible therapeutic target for POCD.

Entities:  

Keywords:  BDNF; Calpain; Cognitive dysfunction; NMDAR; Neuroinflammatioin; Surgery; TrkB

Year:  2020        PMID: 31948437     DOI: 10.1186/s12974-019-1695-x

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


  26 in total

1.  α7 Nicotinic Acetylcholine Receptor May Be a Pharmacological Target for Perioperative Neurocognitive Disorders.

Authors:  Penghui Wei; Wenyuan Lyu; Lin Xu; Hao Feng; Haipeng Zhou; Jianjun Li
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

2.  SLITRK2 variants associated with neurodevelopmental disorders impair excitatory synaptic function and cognition in mice.

Authors:  Salima El Chehadeh; Kyung Ah Han; Dongwook Kim; Gyubin Jang; Somayeh Bakhtiari; Dongseok Lim; Hee Young Kim; Jinhu Kim; Hyeonho Kim; Julia Wynn; Wendy K Chung; Giuseppina Vitiello; Ioana Cutcutache; Matthew Page; Jozef Gecz; Kelly Harper; Ah-Reum Han; Ho Min Kim; Marja Wessels; Allan Bayat; Alberto Fernández Jaén; Angelo Selicorni; Silvia Maitz; Arjan P M de Brouwer; Anneke Vulto-van Silfhout; Martin Armstrong; Joseph Symonds; Sébastien Küry; Bertrand Isidor; Benjamin Cogné; Mathilde Nizon; Claire Feger; Jean Muller; Erin Torti; Dorothy K Grange; Marjolaine Willems; Michael C Kruer; Jaewon Ko; Amélie Piton; Ji Won Um
Journal:  Nat Commun       Date:  2022-07-15       Impact factor: 17.694

3.  Transient neuroinflammation following surgery contributes to long-lasting cognitive decline in elderly rats via dysfunction of synaptic NMDA receptor.

Authors:  Bo Chen; Guangcheng Qin; Jingyu Xiao; Xiaoyuan Deng; Aolei Lin; Hongliang Liu
Journal:  J Neuroinflammation       Date:  2022-07-13       Impact factor: 9.587

4.  VRT-043198 Ameliorates Surgery-Induced Neurocognitive Disorders by Restoring the NGF and BNDF Expression in Aged Mice.

Authors:  Qi Tang; Qiang Guo; Ke Li; Fan Fei
Journal:  Neuropsychiatr Dis Treat       Date:  2022-05-16       Impact factor: 2.989

5.  Postoperative Cognitive Dysfunction and Alzheimer's Disease: A Transcriptome-Based Comparison of Animal Models.

Authors:  Yi-Wei Wang; Liang Wang; Sheng-Jie Yuan; Yuan Zhang; Xin Zhang; Le-Ting Zhou
Journal:  Front Aging Neurosci       Date:  2022-06-28       Impact factor: 5.702

6.  Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor.

Authors:  Bin Mei; Jun Li; Zhiyi Zuo
Journal:  Brain Behav Immun       Date:  2020-10-08       Impact factor: 7.217

Review 7.  Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction.

Authors:  Cong-Mei Wang; Wei-Can Chen; Yan Zhang; Shu Lin; He-Fan He
Journal:  Front Aging Neurosci       Date:  2021-07-08       Impact factor: 5.750

Review 8.  Dendritic spine remodeling and plasticity under general anesthesia.

Authors:  Simon Granak; Cyril Hoschl; Saak V Ovsepian
Journal:  Brain Struct Funct       Date:  2021-06-01       Impact factor: 3.270

9.  Cannabinoid receptor 2 deficiency enhances isoflurane-induced spatial cognitive impairment in adult mice by affecting neuroinflammation, neurogenesis and neuroplasticity.

Authors:  Chao Li; Jingpu Shi; Jiaguang Sun; Yuanyuan Shi; Huiqun Jia
Journal:  Exp Ther Med       Date:  2021-06-25       Impact factor: 2.447

10.  Identification of the Potential Gene Regulatory Networks and Therapeutics in Aged Mice With Postoperative Neurocognitive Disorder.

Authors:  Wensi Wu; Yongpai Peng; Jiaxin Zhou; Xiaojun Zhang; Lin Cao; Wei-Jye Lin; Yanan Lu; Jing Wen; Zhi Wang
Journal:  Front Neurosci       Date:  2021-06-24       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.